Arrayit Establishes Diagnostics Subsidiary in Houston

The subsidiary, called Arrayit Diagnostics, will use its parent's chip platform to identify genomic and proteomic biomarkers for specific diseases, with the aim of making early-stage diagnoses.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.

Related Stories